Stakeholders have responded with concern to the results of the latest Graduate Outcomes Survey, which showed pharmacy graduates received the lowest pay The survey, which was published earlier this week, …

The Pharmacy Board has issued a reminder that pharmacists don’t have long to renew their registration Pharmacists have until 30 November 2019 to renew their registration on time, the Board …

‘In terms of Australia, there are mistakes that can be learnt from Canada’: we speak with an expert about the clinical use of medicinal cannabis Medicinal cannabis is a burgeoning …

Former pharmacist jailed for filming colleagues in bathroom; NZ pharmacists to be paid to deliver MMR; Mississippi county to be left without a pharmacy New Zealand: Minister of Health Julie …

Recommendations on safeguarding the confidentiality of notifiers are imminent from the review conducted in the wake of the attempted murder of a pharmacist A final report on safeguarding the confidentiality …

Retail workers including pharmacy assistants continue to be subjected to a significant amount of sexual harassment in the workplace – and the Guild expects “zero tolerance” by employers In response …

Highlighting the horrific 2019 flu season, the Pharmacy Guild has again called for pharmacy access to the National Immunisation Program The Guild analysed this year’s flu season, which has been …

Canberra pharmacist Elise Apolloni has been named in the ACT’s Mental Health Awards for her work in creating a mentally healthier community and workplace Ms Apolloni, who has in the …

The five finalists in the running for Pharmacy of the Year 2020 have been named There are five finalists in the running for the most anticipated award in community pharmacy: …

A GP has been suspended for prescribing alprazolam, codeine, oxycodone and fentanyl without the proper authority A general practitioner from western Sydney has been reprimanded and suspended for six months …

Health Minister Greg Hunt has highlighted new PBS listings for melanoma and multiple sclerosis treatments On 1 November, the Morrison Government will expand the current PBS listings of Tafinlar (dabrafenib) …

Uncertainty for migraine patients and pharmacists is likely to persist as Novartis pulls PBS application for Aimovig This week Novartis decided to no longer proceed with a third Aimovig (erenumab) …